# Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/roxadustat-fg-4592-versus-epoetin-alfa-for-anemia-in-patients-receiving/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Robert Provenzano,Anatole Besarab,Steven Charles Wright,Sohan Dua,Steven Zeig,Peter Nguyen,Lona Poole,Khalil G. Saikali,Gopal Saha,Stefan Hemmerich,Lynda A. Szczech,K.H.P. Yu,Thomas B. Neff |
| Citations | 262 |
| DOI | 10.1053/j.ajkd.2015.12.020 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1053/j.ajkd.2015.12.020 |
| OpenAlex ID | https://openalex.org/W2272875085 |
| PMID | 26846333 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Anatole Besarab](https://scholariq.org/researchers/anatole-besarab/)

## Paper journal

- [American Journal of Kidney Diseases](https://scholariq.org/journals/american-journal-of-kidney-diseases/)

## Paper primary topic

- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)

## Paper topics

- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Blood transfusion and management](https://scholariq.org/topics/blood-transfusion-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.